The Number 1 Small-Cap Biotech Investors are Missing Out On Post author:Sam Post published:December 26, 2017 Post category:BioPharma A look at a small-cap biotech company that investors should consider. Source: BioSpace You Might Also Like Immunovaccine Appoints Seasoned Financial Executive As CFO February 2, 2017 How Gilead Just Lost $9 Billion in Market Value This Week February 8, 2017 FDA Head Postpones Layoff Notices of Thousands of Employees July 25, 2017
